None listed
Conditions
Interventions
1:none
2:Infliximab
Sponsors
National Sciences Foundation of China
Eligibility
Sex/Gender
All
Age
28 Years to 58 Years
Inclusion criteria
Inclusion criteria: Active rheumatoid arthritis
Exclusion criteria
Exclusion criteria: with severe systemic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| erythrocyte sedimentation rate;C-reactive protein; | — |
Countries
China
Contacts
Public Contactlizhanguo
Outcome results
None listed